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Interactions
ToxicityOne of the most commonly consumed and commercially relevant herbal teas in South Africa is rooibos tea,
prepared from the plant, Aspalathus linearis (Burm. F.) Dahlg. In orthodox medicine, antimicrobial agents are
amongst the most commonly prescribed groups of drugs and thus there is a considerable possibility for the
concurrent use of these drugs with the highly popular beverage, rooibos tea. Therefore, the aim of this study
was to investigate the interactive antimicrobial and toxicity proﬁles of A. linearis (aqueous and organic extract),
when combined with seven conventional antimicrobials (ciproﬂoxacin, erythromycin, gentamicin, penicillin G,
tetracycline, amphotericin B and nystatin). The antimicrobial activity of A. lineariswas evaluated, independently
and in combination, using the minimum inhibitory concentration (MIC) assay against two yeasts, three
Gram-positive and three Gram-negative bacteria. The interactions were further evaluated using the sum of the
fractional inhibitory concentration (∑FIC) assessment. Combinations demonstrating notable synergistic or
antagonistic interactions were investigated in various ratios (isobolograms). The toxicity of A. linearis extracts
and antimicrobials was assessed independently and in combination, using the brine-shrimp lethality assay
(BSLA), and the 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell proliferation assay
on the human HEK-293 cell line. A. linearis (aqueous and organic extract) with penicillin G demonstrated the
most notable interactions, when tested against the Gram-positive bacteria, with∑FIC values ranging from
0.01 (synergistic) to 0.94 (additive). Varied ratio studies of this combination were most synergistic against
Staphylococcus aureus. Four antagonistic combinations were identiﬁed against the Gram-negative bacteria
and yeasts. In the BSLA, no combinations were identiﬁed to be toxic. However, in the MTT assay, two com-
binations were found to demonstrate a possible toxic effect (A. linearis aqueous and organic extract with
nystatin), with inhibitory effects of 73.76 ± 3.36% and 56.88 ± 6.61%, respectively, thus warranting fur-
ther in vivo studies.
© 2014 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
South Africa is culturally diverse, with various medicinal systems
being practised. Very often, beverages such as wine, beer and tea pre-
pared from plants are consumed not only for their cultural relevance,
but for nutritional or medicinal purposes too (Van Wyk and Gericke,
2000). In South Africa, many medicinal plants have been consumed as
herbal teas for decades (Watt and Breyer-Brandwijk, 1932; Van Wyk
and Gericke, 2000; McGaw et al., 2007; Bhat and Moskovitz, 2009;
VanWyk et al., 2009). Some plants fromwhich herbal teas are prepared
include Leyssera gnaphalioides (Hongertee), Plecostachys serpyllifolia
(Hottentots tee), and Viscum capense (Cape Mistletoe), with the more
well-knownplants such asArtemisia afra, Lippia javanica and Sutherlandia27 11 6424355.
Vuuren).
ghts reserved.frutescens often being consumed as teas formedicinal purposes. Themost
commercially relevant teas in South Africa are prepared fromplants such
as Athrixia phylicoides (bush tea or Zulu tea), Cyclopia spp. (honeybush
tea) and Aspalathus linearis (rooibos tea) (Van Wyk and Gericke,
2000). Of these plants, A. linearis has been the most successful in
commercialisation, with a large international demand (Joubert et al.,
2008).
Commercialisation of rooibos started as early as 1904 by Benjamin
Ginsberg, where the tea was marketed as the famous South African
brand, “Eleven O'Clock”. Mass cultivation, however, only started in
the early 1930s. Even though A. linearis only occurs naturally in the
Cederberg area of the Western Cape, South Africa (Dahlgren, 1968),
exporting of the tea to international markets generates millions of
rand per year for the country. The international market for rooibos tea
far outweighs the local demand, as shown by data compiled by the
South African Rooibos Council, where only 18% of the annual yield of
rooibos, both fermented and unfermented, produced in 2007, was for
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for 2007 was for export to international markets, namely Germany
(53%), the Netherlands (11%), United Kingdom (7%), Japan (6%), and
the United States of America (5%) (Joubert et al., 2008). It has been
estimated that annual yields of rooibos tea, for both the local and the
international market range between 4,000,000 kg and 9,000,000 kg
(Van Wyk and Gericke, 2000).
Rooibos tea is not only consumed for the enjoyment of its taste and
aroma, but also for its medicinal properties. The tea has been found to
provide relief for allergies, dermatological problems, asthma, infantile
colic and other gastrointestinal complaints, such as nausea and heart-
burn (Joubert et al., 2008; VanWyk et al., 2009). It has also been report-
ed that rooibos tea can improve appetite, reduce tension and improve
sleep (Morton, 1983). Rooibos tea is not well-known by the general
public for its antimicrobial activity, but there have been some studies
conﬁrming the inhibitory effects of rooibos against certain micro-
organisms, such as Escherichia coli, Staphylococcus aureus, Bacillus cereus,
Listeria monocytogenes, Streptococcus mutans and Candida albicans
(Nakano et al., 1997; Schepers, 2001; Almajano et al., 2008; Coetzee
et al., 2008).
The medicinal properties have drawn extensive attention, with
studies on the anti-oxidant, antimutagenic, anti-allergenic, vasodilatory
and dermatological effects of rooibos tea. A review by Joubert et al.
(2008), on South African herbal teas highlights numerous studies
which have focused on the possible health beneﬁts of rooibos tea,
such as the nitric oxide induced-vasodilatory effects (Persson et al.,
2006); or the immunomodulatory effects, through increased antibody
production (Kunishiro et al., 2001); aswell as the bronchodilatory, anti-
spasmodic and blood pressure lowering effects demonstrated in vivo
(Khan and Gilani, 2006).
Rooibos tea is consumed on a daily basis bymany people throughout
theworld (Jaganyi and Ndlovu, 2001). Previously, tea consumptionwas
only popular in eastern countries. Now thewestern populations are also
enjoying the health beneﬁts offered by teas (Almajano et al., 2008; Chan
et al., 2010). Since rooibos tea is such a popular beverage, as indicated by
the data compiled by the South African Rooibos Council, the possibility
for concurrent consumption with conventional medicine is consider-
able. Rooibos tea is commonly consumed by ill people as a form of
comfort. It is also a beverage that is often consumed in the mornings
with breakfast, when many conventional antimicrobials need to be
taken, which results in the possibility for concurrent use.
Herb–drug interactions have become of great clinical importance,
with websites being dedicated to this issue (www.prescribeguide.
com). Previous studies on the interactions between various teas and
commercial pharmaceutical drugs (Yamazaki, 1996; Isogai et al., 2001;
Zhao et al., 2001; Tiwari et al., 2005; Matsuda et al., 2007) indicate
that there should also be equal importance placed on tea–drug interac-
tions in the clinical setting, as there is on herb–drug interactions. Many
studies have focused on the effects of various plants when consumed in
combination with conventional antibiotics, which was demonstrated in
a review by Van Vuuren and Viljoen (2011). However, only a few scien-
tiﬁc articles could be found on the effects of rooibos tea on conventional
drugs when consumed in conjunction. One such study was by Matsuda
et al. (2007), where it was found that rooibos increased cytochrome
P450 enzyme (CYP3A4) activity in the intestine of rats, which resulted
in the reduced efﬁcacy of the benzodiazepine, midazolam. A review by
Mertens-Talcott et al. (2006), also reported that rooibos induced
CYP450 hepatic enzymes, which resulted in the increased metabolism
of many conventional drugs, such as calcium channel blockers used in
the treatment of cardiovascular disease; and statins used for the treat-
ment of hypercholesterolaemia. These ﬁndings clearly demonstrate
that there is a potential for rooibos to interact with conventional
drugs, due to its effect on hepatic enzymes.
Since rooibos tea is consumed so freely and regularly, there is an
assumption that it is safe and free of toxicity. It has been acknowledged
by McGaw et al. (2007), that potential toxicity of regularly consumedbeverages is an important consideration. There have been no reports
documenting the toxicity seenwith rooibos consumption, at the normal
consumed concentrations of the tea (Joubert et al., 2008). However, the
toxicological aspect of rooibos tea, when consumed in large doses, has
been investigated to some extent. A study by Marnewick et al. (2011),
demonstrated that chronic consumption of rooibos caused no adverse
effects in the kidney or liver of humans.
The toxic effect of rooibos tea when consumed in conjunction with
conventional drugs also needs to be addressed. A few previous studies
have mentioned the possibility of toxicity when rooibos is consumed
together with conventional drugs, due to the ability of rooibos tea to
inhibit hepatic CYP450 enzymes, resulting in reduced metabolism of
conventional drugs when consumed in conjunction (Jang et al., 2004).
However, no studies were identiﬁed, where the effects of A. linearis
combinedwith conventional antimicrobial agents have been investigat-
ed. Therefore, the aim of this study was to determine the interactive
antimicrobial and toxicity proﬁles of A. linearis (aqueous and organic
extract), when placed in combination with seven conventional antimi-
crobial agents.
2. Materials and methods
2.1. Sourcing and preparation of plant samples
A. linearis leaves (4 kg super grade, pasteurised, fermented leaves)
were donated by Rooibos Limited, Clanwilliam, Cape Town. The leaves
were provided in the form in which the tea is commercially sold, ensur-
ing that the plant samples were as closely related to that which is used
by consumers. The leaves were harvested from shrubs growing in the
Clanwilliam region of the Cederberg area. Harvesting occurred during
the warm summer months and the plant material was received at the
University of the Witwatersrand in March 2012.
The dry leaves were ground into a ﬁne powder using a high speed
Fritsch Pulverisette grinder (Labotec). The aqueous extract of A. linearis,
which mimics the traditional form of consumption, was prepared by
submerging the ground plant material in sterile distilled water and left
in a platform shaker/incubator, for 24 h at 25 °C. The liquid was then
ﬁltered and the ﬁltrate stored at−80 °C before lyophilisation (Virtis).
The lyophilised aqueous extract was then left under ultra-violet light
overnight to ensure the elimination of any microbial contamination.
The organic extract of A. linearis was also prepared, even though it is
not used traditionally in this form. This is to ensure the testing of a con-
centrated form of extract prepared from the plant, whichwill ensure the
extraction of both polar and non-polar compounds. To prepare the or-
ganic extract, the plant material was submerged in a mixture of
dichloromethane and methanol (1:1), for 24 h at 37 °C, in a platform
shaker/incubator (Labcon). Thereafter, the liquid was ﬁltered and the
ﬁltrate left in open glass bottles, under a fume hood, for the complete
evaporation of the solvent, leaving behind the solid organic extract. The
percentage yields were calculated at 1.37% and 1.98% for the aqueous
and organic extract respectively, after which the extracts were stored
in sealed sterile bottles, at room temperature and protected from light,
until further analysis.
2.2. Toxicity studies
2.2.1. Brine-shrimp lethality assay
Artiﬁcial sea water was prepared by dissolving 16 g of Tropic
Marine® Sea Salt in 500 ml of distilled water, which was then
dispensed into an inverted, bottomless plastic bottle. Dried, brine-
shrimp (Artemia franciscana) eggs (Ocean Nutrition™) (0.5 g), pur-
chased from a local pet store, were added to the salt water. To ensure
a high hatch rate, the salt water was aerated with a rotary pump
(Kiho) and a constant source of light and warmth from a lamp
(220–240 V) was provided. The eggs were incubated under these
conditions, at 25 °C for 18–24 h.
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water containing 40–60 live brine-shrimp was added to each well
along with 400 μl sample (plant samples, antimicrobials or a combina-
tion of both). All the latter sampleswere studied at a ﬁnal concentration
of 1 mg/ml in triplicate per plate, with plates being duplicated. A
concentration of above 1 mg/ml was considered non-toxic for the
assay (Bussmann et al., 2011). The negative toxic-free control consisted
of 32 g/l artiﬁcial sea water that mimicked the natural environment for
the brine-shrimp, to support their growth and survival. The positive
control consisted of 1.6 mg/ml potassium dichromate, which is a
known highly toxic compound (Sigma-Aldrich). Dead brine-shrimp
were counted after 24 and 48 h by viewing plates under a light micro-
scope (Olympus) at 40× magniﬁcation. After which, a lethal dose of
acetic acid (Saarchem; 100% (v/v); 50 μl) was added to each well, for
a ﬁnal count to be undertaken such as to calculate the percentage
mortality (Cock and Kalt, 2010). A percentagemortality of 50% or great-
er was considered biologically toxic and further varied concentrations
would need to be prepared to determine the dose or concentration
required to have a lethal effect on 50% of the brine-shrimp (LD50)
from a log-sigmoid dose–response curve generated by GraphPad
Prism® (Version 5) software (Bussmann et al., 2011).
2.2.2. The 3-(4,5 dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay
2.2.2.1. Cell culturing and trypsinisation. The human kidney epithelial
(Grahamor HEK-293) cells were cultured in Dulbecco'sModiﬁed Eagles
Medium (Sigma-Aldrich) supplemented with 10% foetal bovine serum
(FBS) (Thermo Scientiﬁc), 1% non-essential amino acids (Sigma-
Aldrich) and 1% penicillin/streptomycin/fungizone mixture (10,000 U
penicillin/ml, 10,000 μg streptomycin/ml and 25 μg fungizone/ml)
(Sigma-Aldrich). Experimental culture media was similar to complete
culture media, however, it did not contain the antimicrobials. In accor-
dance with the methods followed by Mosmann (1983) and van Zyl
et al. (2006), the cells were maintained at 37 °C in 5% CO2 and when
conﬂuency of the cells was reached, the cells were trypsinised to use
in the cell proliferation assay or to reseed a culture. A waiver for the
use of the human kidney epithelial (Graham) cell line was obtained
from the University of theWitwatersrand Human Research Ethics Com-
mittee (Reference W-CJ-120309-3).
2.2.2.2. The MTT cell proliferation assay. Of the 0.5 million cells/ml sus-
pension, 180 μl was added to each well of a sterile 96-well micro-titre
plate (VWR International). To ensure that the cells adhered to the well
surface before addition of the samples, the plates were incubated at
37 °C for 6 h, in a humidiﬁed environment with 5% CO2. The samples
and their combinations were all screened at 100 μg/ml and tested in
triplicatewells, with a colour control (absent of cell suspension) includ-
ed for each sample. A cell-free, sample-free control consisting only of
culture media was also included. Positive controls of quinine and
camptothecin (Sigma-Aldrich) were included for comparison to the
untreated, 100% cell suspension control. The prepared plates were
then incubated at 37 °C for a further 44 h. A washing step was then
undertaken using phosphate buffered saline (pH 7.20; PBS), to ensure
no interference of plant sample colour in absorbance readings and
sample–MTT interaction. Thereafter, 40 μl sterile 5.00 mg/ml MTT
(Sigma-Aldrich) solution was added to each well and plates were
incubated for a further 4 h. A volume of 170 μl of the supernatant was
then removed from each well, ensuring no disruption of the adherent
cells. This was replaced with dimethyl sulphoxide (DMSO) for the
discontinuation of the reaction and to solubilise the formazan crystals.
The absorbance of dissolved crystals was then read (Labsystems
iEMS MF reader) at a test wavelength of 540 nm and reference wave-
length of 690 nm, connected to a computer with Ascent® software.
Percentage cell viability was then calculated using the following equa-
tion, where “Abs” signiﬁes absorbance, and all absorbance values usedin the calculation were derived from deducting the absorbance value
at 690 nm from the absorbance value at 540 nm (Abs540–Abs690)
(Kamatou, 2006):
% Cell viability ¼ Abs test sample– Mean Abs control–Mean Abs blankð Þ  100
Mean Abs control–Mean Abs blankð Þ
Samples were further tested at a concentration of 1 mg/ml for
comparison with the BSLA; however, the colour of the plant samples
resulted in numerous washing steps to prevent the interference
of sample colour in the absorbance readings. Excessive washing
compromised cell viability and therefore these results were not taken
into account.
2.3. Antimicrobial analysis
2.3.1. Minimum inhibitory concentration (MIC) assays
To represent the threemain classes of micro-organisms, three Gram-
positive bacteria; S. aureus (American Type Culture Collection (ATCC)
25923), Enterococcus faecalis (ATCC 29212) and Bacillus cereus (ATCC
11778), three Gram-negative bacteria; Klebsiella pneumoniae (ATCC
13883), E. coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC
27858), and lastly two yeasts; C. albicans (ATCC 10231) and Cryptococcus
neoformans (ATCC 14116) were selected. The pathogens were selected
on the basis of their prevalence in nosocomial infections and their causal-
ity of infections, such as gastrointestinal tract, respiratory tract and skin
infections, for which the selected medicinal plants are traditionally
used. All micro-organisms were cultured in Tryptone Soya broth (TSB)
(Oxoid) and kept viable by sub-culturing. Streak plates were prepared
to ensure the purity of the culture, aswell as for isolation of pure colonies
for sub-culturing. A waiver for the use of these micro-organisms was
obtained from the University of the Witwatersrand Human Research
Ethics Committee (Reference W-CJ-130726-1).
The selected conventional antimicrobials included erythromycin
(potency of≥850 μg/mg), gentamicin (potency of 600 μg/mg), nystatin
(potency of ≥4400 United States Pharmacopoeia (USP) units/mg),
penicillin G (potency of 1440–1680 units/mg), tetracycline [≥95%
High Performance Liquid Chromatography (HPLC)], ciproﬂoxacin
(≥98% HPLC) and amphotericin B (80% HPLC), which were all
purchased from Sigma-Aldrich (South Africa). The antimicro-
bials were prepared in sterile distilled water, while the antifun-
gal, amphotericin B, was dissolved in 1% (v/v) DMSO in sterile
water.
The MIC assay was used to evaluate the antimicrobial activity
of A. linearis aqueous and organic extracts, when tested individually
as well as in combination with the conventional antimicrobials.
The micro-titre plate method to determine the antimicrobial
activity of plant samples were in accordance with methods by
Eloff (1998). The Clinical and Laboratory Standards Institute (CLSI)
guidelines (2012) were also consulted when analysing conventional
antimicrobial drugs.
Each well of the micro-titre plate was ﬁlled with 100 μl of sterilized
distilled water and samples introduced into the wells of the ﬁrst row
as 100 μl for individual samples or 50 μl of each sample in the double
combinations. Plant sampleswere introduced at starting concentrations
of 32 mg/ml in acetone (organic extracts) or sterile water (aqueous
extracts). The conventional antimicrobials were introduced at a starting
concentration of 0.01 mg/ml and 0.1 mg/ml for antibiotics and antifun-
gals, respectively. All samples and plant: antimicrobial combinations
were tested in at least duplicate. The positive control (to conﬁrm
antimicrobial susceptibility) was either ciproﬂoxacin (0.01 mg/ml) or
amphotericin B (0.1 mg/ml) for bacteria and yeasts, respectively.
Three negative controls were used, one of whichwas external to plating
and consisted of a media control, to ascertain sterility of the media
(TSB). Included was the negative culture control of TSB alone, which
was absent of a sample with antimicrobial activity, to allow for the
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trol, which consisted of acetone (32 mg/ml) for organic extract testing.
The solvent control was included to ascertain whether the diluent had
any antimicrobial effects. A serial doubling dilution was undertaken
after all samples had been plated and the plates then inoculated with
the relevant pathogen, ensuring an inoculum of approximately 1 × 106
colony formingunits (CFU)/ml. Plates, sealedwith a sterile adhesive seal-
er, were then incubated at 25 °C for 48 h and 37 °C for 24 h for yeasts and
bacteria, respectively.
After incubation, 40 μl of the colour indicator, ρ-iodonitrotetrazolium
violet (INT; 0.4 mg/ml; Sigma-Aldrich) was added to each well, which
turned purple-pink in the presence of microbial growth. The end point
MIC value was therefore taken as the ﬁrst clear well within a column,
which represented the lowest concentration of test sample that inhibited
microbial growth.
2.3.2. Fractional inhibitory concentration (FIC) assessment
Combinations of A. linearis (aqueous and organic extract) with the
conventional antimicrobial were further assessed using the sum of the
fractional inhibitory concentration (∑FIC), which would allow for the
classiﬁcation of the type of interaction occurring. The FICwas calculated
using the following equation, where (a) represents the plant sample
and (b) the conventional antimicrobial sample (Van Vuuren and
Viljoen, 2011):
FIC ið Þ ¼MIC að Þ in combination with bð Þ
MIC að Þ independently
FIC iið Þ ¼MIC bð Þ in combination with að Þ
MIC bð Þ independently
The∑FIC was calculated using the equation;∑FIC= FIC (i) + FIC (ii).
Depending on the values obtained, the interactions could then be classi-
ﬁed as being synergistic∑FIC (≤0.5), additive (N0.5–1.0), indifferent
(N1.0–≤4.0) or antagonistic (N4.0) in nature (Van Vuuren and
Viljoen, 2011). Tentative interpretations were included, where the
MIC value of one of the individual agents in the combination was greater
than the highest concentration tested (N8 mg/ml). Tentative interpre-
tations provided an indication of the possible interactive proﬁle for
the combination. An∑FIC value was not given since the calculation
can only be undertaken on absolute values and results having ‘greater
than’ values could not be considered in the calculation.
2.3.3. Varied ratio combination studies (isobolograms)
For notable synergistic or antagonistic interactions that were
observed in the∑FIC evaluation, a varied ratio study was undertaken
to determine which agent within the combination was most responsi-
ble for the interactive proﬁle observed. Nine different ratios of theTable 1
The concentration ratios used for antimicrobial and plant sample combination studies.
Volume ratio of
antimicrobial:
plant sample
(μl)
Concentration of
plant sample in
combination
(mg/ml)
Concentration of
antibacteriala in
combination
(μg/ml)
Concentration of
antifungalb in
combination
(μg/ml)
90:10 3.20 9.00 90.00
80:20 6.40 8.00 80.00
70:30 9.60 7.00 70.00
60:40 12.80 6.00 60.00
50:50 16.00 5.00 50.00
40:60 19.20 4.00 40.00
30:70 22.40 3.00 30.00
20:80 25.60 2.00 20.00
10:90 28.80 1.00 10.00
a Ciproﬂoxacin/erythromycin/gentamicin/penicillin G/tetracycline.
b Amphotericin B/nystatin.combination were prepared and the MIC values determined. Table 1
demonstrates the concentrations for each ratio tested. Data points for
each ratio studied were plotted on an isobologram using the GraphPad
Prism® software (Version 5). Data points falling below the 0.5:0.5 line
indicated synergy, while those above the 0.5:0.5 line but below the
1.0:1.0 line indicated an additive effect. Data points above the 1.0:1.0
line, but below the 4.0:4.0 line indicated an indifferent interaction and
those falling above the 4.0:4.0 line indicated antagonism (Van Vuuren
and Viljoen, 2011).
3. Results and discussion
3.1. Toxicity analysis
3.1.1. Brine shrimp lethality assay
The BSLAwas used as a preliminary toxicity screening tool to identi-
fy any possible toxicity of A. linearis aqueous and organic extracts, inde-
pendently, as well as in combination with the selected conventional
antimicrobials. Independently, both the aqueous and organic extracts
demonstrated no toxic effects at 1 mg/ml after 24 and 48 h (Table 2).
When tested individually, most of the conventional antimicrobials
were not toxic against the brine-shrimp, except for gentamicin and
tetracycline both killing less than 10% of the brine-shrimp after 48 h
(Table 2). These two antimicrobials were still not considered toxic in
the BSLA, since the mortality rate at 1 mg/ml was below 50% compared
to the positive control, potassium dichromate. A similar safety proﬁle
was notedwhen the aqueous and organic extract of A. lineariswas com-
bined with the conventional antimicrobials, except for three combina-
tions. Namely, the combinations between A. linearis aqueous extract
and ciproﬂoxacin (31.58 ± 1.53%), A. linearis aqueous extract and
gentamicin (4.35 ± 0.58%) and A. linearis organic extract with erythro-
mycin (6.67 ± 0.58%) (Table 2). However, the degree of mortality
observed does not warrant classifying the interactions as toxic and
should not have had an inﬂuence on the antimicrobial inhibitory effect
observed with these interactions. Neither should they have signiﬁcant
effect on the patient taking the combination.
3.1.2. MTT cell proliferation assay
As in the brine-shrimp assay, the individual aqueous and organic ex-
tract of A. linearis demonstrated no toxicity in the MTT assay (Table 2).
Similarly, no toxicity was observed for the individual conventional
antimicrobials, with all antimicrobials demonstrating a cell viability
of approximately 100%, except for amphotericin B (cell viability of
94.07 ± 3.41%) (Table 2). To account for possible interactions between
extracts and the MTT, appropriate controls and washing steps were
included. Increased formazan production was noted for some of the
samples, which could have been due to either increased mitochondrial
activity or increased cell numbers.
The lack of toxicity for A. linearis on human kidney epithelial cells is in
accordance with ﬁndings byMarnewick et al. (2003), who reported that
an aqueous extract of fermented and unfermented rooibos displayed no
toxic effects on rat kidneys when provided as the only drinking ﬂuid for
the rats over a 10week period. Later, Marnewick et al. (2011) also found
that fermented rooibos had no adverse effects on kidney function in 83
human male and female participants from Cape Town, when six cups
of rooibos tea were consumed per day for six weeks. Even though
some of the kidney function indicators were increased after the test
period, all were still within reference ranges, therefore supporting the
safety of short term rooibos consumption.
The combinations of A. linearis (aqueous and organic extract) with
six of the seven conventional antimicrobials, demonstrated no potenti-
ation or induction of toxicity (Table 2). However, the combination of
both the A. linearis aqueous and organic extracts with the antifungal
agent, nystatin, demonstrated a possible toxic effect, with cell growth
being inhibited by 73.76± 3.36% and 56.88± 6.61%, respectively. Nys-
tatin has been shown to cause cellular toxicity towards J774
Table 2
Mortality (%) and cell death (%) results for the BSLA and the MTT assay, respectively.
Sample or combination Mortality (% ± S.D.)a Cell death (% ± S.D.)b
After 24 h: After 48 h: After 48 h:
Antimicrobials Ciproﬂoxacin 0.00 0.00 0.1 ± 0.01
Erythromycin 0.00 0.00 0.1 ± 0.01
Gentamicin 1.12 ± 0.58 8.99 ± 0.33 0.1 ± 0.01
Penicillin 0.00 0.00 0.1 ± 0.01
Tetracycline 0.00 6.67 ± 1.16 0.1 ± 0.01
Amphotericin 0.00 0.00 5.93 ± 3.41
Nystatin 0.00 0.00 0.1 ± 0.01
Aqueous extract A. linearis 0.00 0.00 0.1 ± 0.01
A. linearis + ciproﬂoxacin 0.00 31.58 ± 1.53 0.1 ± 0.01
A. linearis + erythromycin 0.00 0.00 0.1 ± 0.01
A. linearis + gentamicin 0.00 4.35 ± 0.58 0.1 ± 0.01
A. linearis + penicillin 0.00 0.00 0.1 ± 0.01
A. linearis + tetracycline 0.00 0.00 0.1 ± 0.01
A. linearis + amphotericin 0.00 0.00 0.1 ± 0.01
A. linearis + nystatin 0.00 0.00 73.76 ± 3.36
Organic extract A. linearis 0.00 0.00 0.1 ± 0.01
A. linearis + ciproﬂoxacin 0.00 0.00 0.1 ± 0.01
A. linearis + erythromycin 0.00 6.67 ± 0.58 0.1 ± 0.01
A. linearis + gentamicin 0.00 0.00 0.1 ± 0.01
A. linearis + penicillin 0.00 0.00 0.1 ± 0.01
A. linearis + tetracycline 0.00 0.00 0.1 ± 0.01
A. linearis + amphotericin 0.00 0.00 0.1 ± 0.01
A. linearis + nystatin 0.00 0.00 56.88 ± 6.61
Controls Camptothecin 0.00a 2.08 ± 0.58a 76.07 ± 2.94a
30.00 ± 2.00b 100.00b 0.1 ± 0.01b
Quinine 0.00a,b 0.00a 71.38 ± 4.73a
11.76 ± 1.00b 0.1 ± 0.01b
Potassium dichromate 100.00c NA
NA = control not tested in or relevant to the assay; S.D. = standard deviation.
a Final concentration of 1 mg/ml.
b Final concentration of 100 μg/ml.
c Tested at a concentration of 1.6 mg/ml.
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lower than tested in this study, did not affect the viability of RAW 264.7
leukaemia cells (Tzimogianni et al., 1989). The possibility for nystatin to
interact with rooibos to cause nephrotoxicity is unlikely, since nystatin
has negligible absorption into the systemic circulation, thus passing
the renal excretory pathway (SAMF, 2012). Intravenously administered
nystatin is known to possess toxicity and as such is now only adminis-
tered topically,where the drug penetrates the surface layer (epidermis),
but does not transverse to the blood stream (Sheppard and Lampiris,
2012; LIFE, 2013). Topical adverse effects have been reported to include
hypersensitivity, skin irritation and pruritis (Sheppard and Lampiris,
2012). Nystatin entering the gastrointestinal tract is excreted un-
changed, however, the possibility for other cellular interactions in the
gastrointestinal tract should beobserved. The possibility of rooibos facil-
itating increased uptake of nystatin through the gastrointestinal wall
into the systemic circulation should also be considered. An in vitro
study by Tarirai et al. (2012) using Caco-2 cell monolayers and
excised porcine jejunum tissue, has already shown that rooibos tea
can have an effect on the intestinal absorptive proﬁle of the convention-
al drug, cimetidine. As such, extended in vivo studies on the pharmaco-
kinetic and pharmacodynamic properties of the combinations are
warranted.
3.2. Antimicrobial analysis
3.2.1. Antimicrobial activity of individual samples
The antimicrobial activities of the conventional antimicrobials are al-
ready well-known. Antimicrobial activity of these agents was, however,
still evaluated independently in this study, to provide the necessary
data for the overall interactive evaluation. Testing these antimicrobials
independently also validated the reliability of the micro-dilution assay,
to ensure that theMIC values obtained in this study were in accordance
with break point expectations (Andrews, 2004; CLSI, 2012). The MICvalues obtained were all congruent with the break point expectations;
except for tetracycline against E. faecalis and P. aeruginosa, where
these two strains demonstrated an enhanced susceptibility towards
tetracycline. Break point expectations are derived from published anti-
microbial analysis of samples against various pathogens, providing a
range for the expected MIC value of a speciﬁc antimicrobial agent
against a pathogen.
When A. linearis was investigated individually for antimicrobial
activity, no noteworthy antimicrobial activity was identiﬁed for both
the aqueous and organic extracts. Noteworthy antimicrobial activity of
extracts was deﬁned as MIC values of b1.00 mg/ml (Ríos and Recio,
2005; Van Vuuren, 2008; Ncube et al., 2012). The lack of noteworthy
antimicrobial activity demonstrated by A. linearis was expected, since
rooibos tea is more commonly known for its antimutagenic and antiox-
idant activity, rather than for its antimicrobial activity (Van Wyk et al.,
2009). Many studies have investigated the antimicrobial properties of
green and black tea (Toda et al., 1989; Diker et al., 1991; Fukai et al.,
1991; Diker and Hascelik, 1994; Yeo et al., 1995), however, very little
has been done on the antimicrobial properties of rooibos. Two studies
that investigated the antimicrobial activity of extracts of A. lineariswere
conducted by Schepers (2001) and Coetzee et al. (2008). Schepers
(2001) tested the soluble solids of unfermented and fermented rooibos
extract at concentrations varying from 0.50 g/l to 5.00 g/l, against a
range of pathogens. The growth of the pathogens in the presence of the
extracts was determined spectrophotometrically. It was found that
rooibos had an inhibitory effect on E. coli, S. aureus and B. cereus growth
after 12 h. For the soluble solids from the unfermented rooibos, the per-
centage decrease in growth ranging from 10.20 to 35.10% for E. coli, 5.70
to 50.10% for S. aureus and 9.40% to 47.50% for B. cereus, when tested at
concentrations ranging from 0.50 to 5.00 g/l. The soluble solids from
the fermented rooibos demonstrated a percentage decrease in growth
of 14.30–69.00% for E. coli, 8.20–90.8% for S. aureus and 14.40–80.30%
for B. cereus, when tested at concentrations ranging from 0.50 to
153Z. Hübsch et al. / South African Journal of Botany 93 (2014) 148–1565.00 g/l. These three pathogens were also included in the current study,
with both the aqueous and organic extracts displaying the best antimi-
crobial activity against E. coli (MIC value of 1.50 mg/ml). Coetzee et al.
(2008) also identiﬁed the inhibitory effects of rooibos extracts against
E. coli, but the extracts were tested at very high concentrations and the
inhibitory effect was only seen at a concentration of 10 mg/ml, therefore
cannot be considered noteworthy as an antimicrobial.3.2.2. Combination studies
3.2.2.1. Fractional inhibitory concentration assessment. A total of 56
combinations were evaluated and ∑FIC calculations recorded in
Tables 3.1–3.3 for the Gram-positive, Gram-negative bacteria and
yeasts, respectively. Of these combinations, 19.64% were synergistic,
7.14% were antagonistic, 19.64% were additive and 53.57% were found
to be indifferent in nature. The indifferent interactions noted between
the majority of the combinations of the A. linearis extracts with the
conventional antimicrobials, alleviate some concern related to their
concurrent use, as no advantage or disadvantage is associated with
this type of interaction.
The most synergistic interactions were found against the Gram-
positive bacteria, when A. linearis was combined with penicillin G,
where the combination was most synergistic against S. aureus
(Table 3.1). It is highly likely that one of the constituents of the extracts
could have potentiated the uptake and antimicrobial effect of the antibi-
otic. Studies have found that epigallocatechin-3-gallate (EGEG), a com-
pound commonly found in many teas, has a synergistic effect with the
β-lactam antibiotics, such as penicillin, and their derivatives, when
tested against methicillin-resistant S. aureus (MRSA) (Yamazaki, 1996;
Zhao et al., 2001; Hu et al., 2002). EGEG is not found in rooibos tea
(Almajano et al., 2008), but further studies are warranted to identify
the compound/s and mechanism of action by which this strong syner-
gistic interaction is facilitated. It has been reported that penicillin G
has been found to possess a mostly potentiating or synergistic effect
when in combination with other plants, such as Catha edulis, where a
fourfold potentiation of penicillin G against Fusobacterium nucleatum
was seen (Al-hebshi et al., 2006). Rhus coriaria, Sacropoterium spinosumTable 3.1
MIC (μg/ml) and∑FIC values for the combination of A. lineariswith the various antibiotics, ag
S. aureus (ATCC 25923)
Combination Sampletype
A. linearis +
ciprofloxacin
Aq
Cip
≥ 8000
0.47
2000
0.63
NA IND
≥ 8000
0.63
Org
Cip
3000
0.47
500
0.16
0.51 ADD
2000
0.63
A. linearis +
erythromycin
Aq
Ery
≥ 8000
0.32
2000
0.63
NA IND
≥ 8000
0.32
Org
Ery
3000
0.32
2000
0.63
2.70 IND
2000
0.32
A. linearis +
gentamicin
Aq
Gen
≥ 8000
1.88
≥ 4000
≥ 1.25
NA ADD
≥ 8000
≥ 2.50
Org
Gen
3000
1.88
1000
0.32
0.50 SYN
2000
≥ 2.50
A. linearis +
penicillin G
Aq
Pen
≥ 8000
≥ 2.50
30
0.01
NA SYN
≥ 8000
≥ 2.50
Org
Pen
3000
≥ 2.50
30
0.01
0.01 SYN
2000
≥ 2.50
A. linearis +
tetracycline
Aq
Tet
≥ 8000
0.23
1000
0.32
NA IND
≥ 8000
0.16
Org
Tet
3000
0.23
500
0.16
0.87 ADD
2000
0.16
Indiv
MIC
Combine
MIC ∑FIC Int
Indiv
MIC
Shaded areas indicate the MIC values as determined for the individual samples, which have
Indiv = MIC for individual samples; Combine = MIC for samples when in combination; Int
value cannot be attained and are therefore referred to as a tentative interpretation; ADD = adand Rosa damasecena were also found to be synergistic in combina-
tion with penicillin G, when tested against three clinical strains of
P. aeruginosa (Adwan et al., 2010). Penicillin G has also shown strong
potentiating activitywhen in combinationwith someplant compounds,
such as eugenol, thymol and carvacrol, when tested against E. coli,
S. aureus, Streptococcus pyogenes and Salmonella typhimurium. The
strongest synergistic effect was seen against S. aureus (∑FIC of 0.11)
when carvacrol and penicillin G were combined (Palaniappan and
Holley, 2010). In the current study, the strongest synergistic effect for
the combination of A. linearis extracts and penicillin G was also seen
against S. aureus (Table 3.1). Antagonistic interactions were minimal,
with only four antagonistic∑FIC values identiﬁed when A. linearis
was combined with ciproﬂoxacin, gentamicin and amphotericin B. No
antagonism was noted against the tested Gram-positive pathogens
(Tables 3.2 and 3.3).
In a study by Tiwari et al. (2005), the combined antimicrobial activ-
ities of green and black tea extracts with chloramphenicol, gentamicin,
methicillin or nalidixic acid were found to be mostly synergistic against
enteropathogens. This could mean that tea drinkers experience an en-
hanced therapeutic effect of an antimicrobial agent, thereby recovery
from an infection may be more rapid.3.2.2.2. Varied ratio combination studies (isobolograms). Rooibos tea
is not consumed in ﬁxed concentrations. People vary the number of
cups of tea they consume per day. Also, the concentration of active
ingredients varies depending on how long the teabag is left to draw,
thereby varying the strength of the tea. Variations in season, cultivation,
harvesting and leaf preparation may result in a changed concentration
of active ingredients. To determine whether different concentrations
of rooibos inﬂuence the interaction when in combination with an anti-
microbial agent, the combinations were assessed at various ratios. The
combinations demonstrating the most notable synergistic interactions
in the∑FIC evaluation were tested against the Gram-positive patho-
gens when A. linearis (aqueous and organic extract) was combined
with penicillin G. Thus, varied ratios of these combinations were
analysed against the three Gram-positive bacteria, namely B. cereus,
E. faecalis and S. aureus.ainst the Gram-positive pathogens.
B. cereus (ATCC 11778) E. faecalis (ATCC 29212)
Combine
MIC ∑FIC Int
2000
0.63
NA IND
3000
1.25
2000
0.63
1.17 IND
1000
0.32
1.01 IND
2000
1.25
1500
0.47
1.13 IND
1000
0.32
NA IND
3000
1.25
4000
1.25
NA IND
500
0.16
0.77 ADD
2000
1.25
≥ 4000
≥ 1.25
NA IND
3000
0.94
NA IND
3000
≥ 2.50
≥ 4000
≥ 1.25
NA IND
500
0.16
NA SYN
2000
≥ 2.50
500
0.16
NA SYN
250
0.08
NA SYN
3000
≥ 2.50
1000
0.32
0.46 SYN
130
0.04
0.08 SYN
2000
≥ 2.50
1500
0.47
0.94 ADD
250
0.08
NA ADD
3000
≥ 2.50
3000
0.94
NA IND
190
0.06
0.48 SYN
2000
≥ 2.50
2000
0.63
NA IND
Indiv
MIC
Combine
MIC ∑FIC Int
been given here as a point of reference; Aq = aqueous extract; Org = organic extract;
= interaction classiﬁcation; NA = where ≥MIC values are observed, an absolute∑FIC
ditive interaction; IND = indifferent interaction; and SYN = synergistic interaction.
Table 3.2
MIC (μg/ml) and∑FIC values for the combination of A. lineariswith the various antibiotics, against the Gram-negative pathogens.
E. coli (ATCC 25922) K. pneumoniae (ATCC 13883) P. aeruginosa (ATCC 27853)
Combination
Sample
type
Combine
MIC
∑FIC Int CombineMIC ∑FIC Int
Combine
MIC
∑FIC Int
A. linearis +
ciprofloxacin
Aq
Cip
1500
0.08
1000
0.32
4.67 ANT
4000
0.63
500
0.16
0.64 ADD
≥ 8000
0.16
1500
0.47
3.13 IND
Org
Cip
1500
0.08
500
0.16
2.33 IND
3000
0.63
190
0.06
0.16 SYN
3000
0.16
500
0.16
1.17 IND
A. linearis +
gentamicin
Aq
Gen
1500
≥ 2.50
≥ 4000
≥ 1.25
NA IND
4000
≥ 2.50
2000
0.63
NA ADD
≥ 8000
0.32
1500
0.47
1.71 IND
Org
Gen
1500
≥ 2.50
3000
0.94
2.38 IND
3000
≥ 2.50
2000
0.63
NA ADD
3000
0.32
≥ 4000
≥ 1.25
NA ANT
A. linearis +
tetracycline
Aq
Tet
1500
1.25
≥ 4000
≥ 1.25
NA IND
4000
1.25
≥ 4000
≥ 1.25
NA IND
≥ 8000
≥ 2.50
1500
0.47
NA SYN
Org
Tet
1500
1.25
3000
0.94
2.75 IND
3000
1.25
≥ 4000
≥ 1.25
NA IND
3000
≥ 2.50
1500
0.47
NA ADD
Indiv
MIC
Indiv
MIC
Indiv
MIC
Shaded areas indicate the MIC values as determined for the individual samples, which have been given here as a point of reference; Aq = aqueous extract; Org = organic extract;
Indiv = MIC for individual samples; Combine = MIC for samples when in combination; Int = interaction classiﬁcation; NA = where ≥ MIC values are observed, an absolute∑FIC
value cannot be attained and are therefore referred to as a tentative interpretation; ADD = additive interaction; IND = indifferent interaction; SYN = synergistic interaction; and
ANT = antagonistic interaction.
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(Fig. 1a), all ratios were found to be either synergistic or additive in
nature, with no ratios falling above the 1.0:1.0 line. The penicillin G:
A. linearis aqueous extract ratio, consisting of equal volumes of each
agent in the combination (50:50 μl; antimicrobial: plant sample)
(refer to Table 1 for ratio concentrations) was found to be synergistic
against all three Gram-positive pathogens. When the extract and
antimicrobial were combined in equal volumes (50:50 μl), the concen-
tration of rooibos in the ratio was 16 mg/ml (Table 1). Schepers
(2001) found that the average concentration of a cup of rooibos tea is
2 mg/ml, therefore, the ratio consisting of equal volumes of extract
and antimicrobial, would require eight cups of tea to be consumed
with 5.00 μg/ml of penicillin G for the strong synergistic interaction to
occur (Table 1). The combination of A. linearis (aqueous extract) and
penicillin G in varied ratios was mostly synergistic against S. aureus,
with six of the nine ratios being highly synergistic (Fig. 1a), which
supports the∑FIC evaluation. The three penicillin G: A. linearis ratios
for the aqueous extract combination that were not synergistic against
S. aureus, were the 3:7; 2:8 and 1:9 ratios, indicating that a high ratio
of A. linearis aqueous extract is preferred to optimise the antimicrobial
action of penicillin G.
For the combination of the organic extract of A. linearis and penicillin
G, all ratios were found to be either synergistic or additive, except for
two ratios against B. cereus, which were identiﬁed as being indifferent.
Interestingly, again, the penicillin G: A. linearis organic extract ratio,Table 3.3
MIC (μg/ml) and∑FIC values for the combination of A. lineariswith the various antifungal age
C. albicans (ATCC 10231)
Combination Sample
type
Combine
MIC
∑FIC
A. linearis +
amphotericin B
Aq
Amp
≥ 8000
1.56
≥ 4000
≥ 12.50
NA
Org
Amp
3000
1.56
1500
4.69
3.51
A. linearis +
nystatin
Aq
Nys
≥ 8000
2.34
1500
4.69
NA
Org
Nys
3000
2.34
1000
3.13
1.67
Indiv
MIC
Shaded areas indicate the MIC values as determined for the individual samples, which have
Indiv = MIC for individual samples; Combine = MIC for samples when in combination; Int
value cannot be attained and are therefore referred to as a tentative interpretation; ADD = adconsisting of equal volumes of each agent in the combination
(50:50 μl) (refer to Table 1, for ratio concentrations) was found to be
synergistic against all three Gram-positive pathogens. The organic
extract combination, similar to that of the aqueous extract combination
with penicillin G in varied ratios, was most synergistic against S. aureus,
where all nine of the tested ratios were found below the 0.5:0.5 line
(Fig. 1b).4. Conclusions
This study has shown that rooibos tea when taken in combination
with conventional antimicrobials results in interactions that are mostly
indifferent and additive in nature. This alleviates some of the concern
related to the concurrent use of rooibos tea with antimicrobials. Some
notable interactions were identiﬁed in this study, which would require
further in vivo studies for conﬁrmation. The most synergistic interac-
tions were identiﬁed for the combinations with penicillin G against
the Gram-positive pathogens. Synergistic interactions are very often
considered advantageous, as it could result in the enhanced efﬁcacy of
the conventional drugs, allowing for a dose reduction and fewer side
effects. Therefore, the synergy observed supports the statement that
tea and antibiotic combinations could be useful in reducing drug-
resistance problems, due to the potentiating effect (Abascal and
Yarnell, 2002).nts, against the yeasts.
C. neoformans (ATCC 14116)
Int Combine
MIC
∑FIC Int
ANT
≥ 8000
0.39
750
2.35
NA ANT
IND
1500
0.39
130
0.39
1.09 IND
IND
≥ 8000
1.56
1500
4.70
NA IND
IND
1500
1.56
190
0.59
0.51 ADD
Indiv
MIC
been given here as a point of reference; Aq = aqueous extract; Org = organic extract;
= interaction classiﬁcation; NA = where ≥MIC values are observed, an absolute∑FIC
ditive interaction; IND = indifferent interaction; and ANT = antagonistic interaction.
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Fig. 1. Isobologram for A. linearis aqueous (a) and organic (b) extract in combination
with penicillin G, when tested at various ratios against the Gram-positive micro-
organisms (■= S. aureus; = B. cereus; = E. faecalis).
155Z. Hübsch et al. / South African Journal of Botany 93 (2014) 148–156Rooibos, independently and in combination with the conventional
antimicrobials showed no toxic effects in the BSLA and MTT assay,
except for the combination of A. linearis with nystatin in the latter
assay. Nystatin on its own should not cause systemic effects as it is not
absorbed across the gastrointestinal tract (SAMF, 2012), but in combi-
nation with A. linearis, it is possible that the cellular or systemic uptake
of nystatin could be facilitated by a component/s in the extract.
Future recommendations include mechanism of action studies
regarding the combinations. The current study has demonstrated the
potential for tea–drug interactions and therefore emphasises the need
for further tea–drug interaction studies to be conducted with other
conventional drugs. Future tea–drug in vivo studies are also warranted,
to support the in vitro ﬁndings, particularly for the combination of
A. lineariswith nystatin.
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